Rockwell Medical (NASDAQ:RMTI) Rating Increased to Hold at Wall Street Zen

Rockwell Medical (NASDAQ:RMTI) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Saturday.

Separately, HC Wainwright cut their price objective on shares of Rockwell Medical from $7.00 to $3.00 and set a “buy” rating for the company in a research report on Monday, March 24th.

Rockwell Medical Stock Down 3.1%

RMTI stock opened at $0.94 on Friday. The stock has a fifty day moving average of $1.05 and a 200-day moving average of $1.57. Rockwell Medical has a fifty-two week low of $0.86 and a fifty-two week high of $5.15. The company has a market capitalization of $32.12 million, a price-to-earnings ratio of -18.80 and a beta of 1.61. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41.

Rockwell Medical (NASDAQ:RMTI) last posted its earnings results on Monday, May 12th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Rockwell Medical had a positive return on equity of 8.55% and a negative net margin of 1.25%. The company had revenue of $18.91 million for the quarter, compared to analysts’ expectations of $17.46 million. As a group, equities research analysts predict that Rockwell Medical will post 0.03 earnings per share for the current year.

Insider Transactions at Rockwell Medical

In other Rockwell Medical news, major shareholder Larson Family Inve Irrevocable acquired 57,000 shares of the business’s stock in a transaction dated Thursday, April 10th. The stock was bought at an average price of $1.07 per share, with a total value of $60,990.00. Following the completion of the acquisition, the insider now owns 3,527,000 shares of the company’s stock, valued at $3,773,890. This trade represents a 1.64% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Over the last quarter, insiders have sold 10,680 shares of company stock valued at $11,552. 1.90% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Rockwell Medical

A number of institutional investors and hedge funds have recently bought and sold shares of RMTI. Raymond James Financial Inc. purchased a new stake in shares of Rockwell Medical during the 4th quarter valued at $28,000. Geode Capital Management LLC increased its stake in Rockwell Medical by 4.3% in the fourth quarter. Geode Capital Management LLC now owns 320,416 shares of the company’s stock valued at $654,000 after acquiring an additional 13,122 shares during the last quarter. XTX Topco Ltd raised its position in Rockwell Medical by 58.0% during the fourth quarter. XTX Topco Ltd now owns 44,962 shares of the company’s stock valued at $92,000 after purchasing an additional 16,507 shares in the last quarter. Dimensional Fund Advisors LP bought a new stake in Rockwell Medical during the fourth quarter worth about $146,000. Finally, LPL Financial LLC lifted its stake in Rockwell Medical by 91.3% during the fourth quarter. LPL Financial LLC now owns 54,872 shares of the company’s stock worth $112,000 after purchasing an additional 26,191 shares during the last quarter. 23.31% of the stock is owned by hedge funds and other institutional investors.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.